MTOR and rheumatoid arthritis: We predicted that the proteins BCL2L1, MAPK14, CTNNB1, TP53, EIF4EBP1, HIF1a, HMGB, and mTOR would be potential direct targets of Tan IIA in the treatment of rheumatoid arthritis.